THE WAYS OF SYMPATHETIC SYSTEM OVERACTIVITY BLOCKING: RILMENIDINE VERSUS ATENOLOL

Aim. To evaluate effects of long-term treatment with rilmenidine compared with atenolol on lipid and glucose metabolism and cardiovascular remodeling in hypertension. Material and methods. 37 patients with hypertension were randomized to rilmenidine 1-2 mg/day or atenolol 50-100 mg/day for 26 weeks....

Descripció completa

Dades bibliogràfiques

Autors principals:	Y. R. Kasherininov, E. K. Shavarova, A. A. Shavarov, N. V. Vachrameeva, A. N. Krutikov, E. V. Smirnova, A. O. Коnrady, E. V. Shlyakhto
Format:	Artigo
Idioma:	Inglês
Publicat:	Столичная издательская компания 2016-01-01
Col·lecció:	Рациональная фармакотерапия в кардиологии
Matèries:	arterial hypertension glucose tolerance lipid profile left ventricular hypertrophy endothelial function rilmenidine atenolol
Accés en línia:	https://www.rpcardio.online/jour/article/view/1013
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!